Bi-weekly Virology Seminar Series
It is essential for researchers to keep abreast of the work being done by colleagues in a variety of disciplines. To facilitate this, the UCLA-CDU CFAR and the UCLA AIDS Institute sponsors a bi-monthly conference featuring presentations made by researchers working in both basic and translational sciences, clinical therapeutics and biomedical prevention. The topics covered include, among many others, host-virus interactions, novel therapeutics, vaccines, stem-cell research, aging, and viral pathogenesis. The Bi-monthly Multidisciplinary Virology Seminar Series is an in-person meeting from 9:00am to 10:00am in the Biomedical Science Research Building (BSRB) 154 every other Tuesday (see schedule below). A light breakfast will be available during the meeting.
Whether you’re a long-time attendee or joining us for the first time, we can’t wait to dive back into the latest breakthroughs and discussions in the field of virology.
| Date | Room | Presenter 1 | Title | Presenter 2 | Title |
|---|---|---|---|---|---|
| 09/10/24 | BSRB 154 | Arjit Vijey Jeyachandran | “Mpox antiviral development and mouse model” | Jian Zhang | “Modeling HSPC based anti-HIV-1 gene therapy in NHP” |
| 09/24/24 | BSRB 154 | Xiaoyu Liu | “Molecular Sociology of Cellular Condensates Enabling Reovirus Assembly and Replication” | Pablo Alvarez | “Unraveling alphavirus neuroinvasion: Molecular insights from a stem cell derived blood brain barrier model” |
| 10/08/24 | BSRB 154 | William Mu | “Rapamycin treatment improve anti-HIV CAR T cell functions” | ||
| 10/22/24 | BSRB 154 | Justin Meyer, UCSD; Sponsoring faculty: Jamie Lloyd-Smith | “Unfolding Evolution: How Destabilizing Mutations Enable Viruses to Adapt to New Receptors” | ||
| 11/19/24 | BSRB 154 | Zheng Cao | "Glycolysis Responsive Nanocapsules for Inflammation-site Targeting" | Margaret Wang | "Engineering enhanced anti-HIV CAR T-cells using CRISPR/Cas9" |
| 12/03/24 | BSRB 154 | Bala Arumugam | “Targeting HIV-1infection with bNAb-based mono-specific and bi-specific Chimeric Antigen Receptor” | Shallu Tomer | "Development of an Advanced Glia-Immune Humanized Mouse Model for Investigating HIV-CNS Infection and Neuroinflammation" |
| 12/17/24 | NO MEETING | ||||
| 12/31/24 | NO MEETING | ||||
| 01/14/25 | CANCELLED | ||||
| 01/28/25 | CANCELLED | ||||
| 02/11/25 | BSRB 154 | Wenting Chen | "Enhanced Delivery of Broadly Neutralizing Antibodies for Targeting CNS Infections." | Jeff Harding | "Effects of cannabis on immune aging." |
| 02/25/25 | BSRB 154 | Chris Hofmann | "T-Cell Receptor Gene Therapy for Human Papillomavirus" | Nandita Kedia | "HSCs-derived CAR-M for Alzheimer’s disease" |
| 03/11/25 | BSRB 154 | Shipra Shirma | "The role of phosphorylation in regulating virus-host protein complexes" | Brian Nguyen | "Development of antiviral oligonucleotides against SARS-CoV-2" |
| 03/25/25 | BSRB 154 | Yennifer Delgado | “Phosphorylation as a driver of functional diversity: a look at SARS-CoV-2 Membrane protein." | Ayub Ali | "Engineering bispecific CAR targeting HCMV and HIV-1" |
| 04/08/25 | BSRB 154 | Javier Ibarrondo | "Anti-HIV Chimeric Antibodies" | Xiaoying Cai | "Structural Heterogeneity of the Rabies Virus Virion" |
| 04/22/25 | BSRB 154 | Declan Winters | “Host-Driven Phosphorylation of Viral Proteins as a Regulatory Mechanism during Alphavirus Infection“ | Lenka Milojevic | "Capturing intermediates and membrane remodeling in class III viral fusion” |
| 05/06/25 | BSRB 154 | Erin Kim | Izra Abbaali | ||
| 05/20/25 | BSRB 154 | Chris Luthers | TBD | ||
| 06/03/25 | BSRB 154 | Eva Segura Gensler | Kevyn Hart | ||
| 06/17/25 | BSRB 154 | Martin Ruvalcaba | TBD |